據報交行對接房企融資協調機制審批授信額度近200億人幣
據《上海證券報》報道,自實施城市房地產融資協調機制後,交通銀行(03328.HK)(601328.SH)已為協調機制名單項目審批授信額度近200億元人民幣,分別在青島、廣西及江西等地實現項目投放落地。
截至2月17日,青島分行已為名單項目中條件較成熟的兩個住宅項目分別發放房地產開發貸款,及時滿足項目建設用款需求。
針對南寧市城市房地產融資協調機制推送的第一批房地產項目,交通銀行廣西壯族自治區分行立即組織開展排摸對接,成功為名單項目發放房地產開發貸款。
此外,交通銀行江西省分行收到當地城市房地產融資協調機制推送名單項目後,快速實現對名單中某民營企業住宅項目放款,有力支持項目建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.